LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Pethani, Jignesh P"
  2. AU="Yilmaz, Hayriye"
  3. AU="Brooks, Joanna M"
  4. AU="Bogan, C"
  5. AU="Acevedo, David"
  6. AU="Runjhun, Rashmi"
  7. AU="McGettigan, Benjamin"
  8. AU="Do, Xuan Long"
  9. AU="Hadváry, P"
  10. AU="M.Vas'uth, "
  11. AU="Aliev, Gjumrakch"
  12. AU="Kędziora, Kamila"
  13. AU=Petralia Ronald S.
  14. AU="Shirwaiker, Rohan A"
  15. AU="Heitkamp, Sara"

Suchergebnis

Treffer 1 - 3 von insgesamt 3

Suchoptionen

  1. Artikel: Discovery of

    Agarwal, Sameer / Sasane, Santosh / Shah, Hardik A / Pethani, Jignesh P / Deshmukh, Prashant / Vyas, Vismit / Iyer, Pravin / Bhavsar, Harsh / Viswanathan, Kasinath / Bandyopadhyay, Debdutta / Giri, Poonam / Mahapatra, Jogeswar / Chatterjee, Abhijit / Jain, Mukul R / Sharma, Rajiv

    ACS medicinal chemistry letters

    2020  Band 11, Heft 4, Seite(n) 414–418

    Abstract: NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases. In this study, rationally designed mimics of sulfonylurea moiety were investigated as NLRP3 inhibitors. Our results culminated into discovery of series ...

    Abstract NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases. In this study, rationally designed mimics of sulfonylurea moiety were investigated as NLRP3 inhibitors. Our results culminated into discovery of series of unprecedented
    Sprache Englisch
    Erscheinungsdatum 2020-02-27
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 1948-5875
    ISSN 1948-5875
    DOI 10.1021/acsmedchemlett.9b00433
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

  2. Artikel ; Online: Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.

    Agarwal, Sameer / Pethani, Jignesh P / Shah, Hardik A / Vyas, Vismit / Sasane, Santosh / Bhavsar, Harsh / Bandyopadhyay, Debdutta / Giri, Poonam / Viswanathan, Kasinath / Jain, Mukul R / Sharma, Rajiv

    Bioorganic & medicinal chemistry letters

    2020  Band 30, Heft 21, Seite(n) 127571

    Abstract: NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent and orally bioavailable NLRP3 ... ...

    Abstract NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent and orally bioavailable NLRP3 inhibitors. Compound 7 was found to be potent (IL-1β IC
    Mesh-Begriff(e) Administration, Oral ; Animals ; Betacoronavirus ; COVID-19 ; Cell Line, Tumor ; Coronavirus Infections ; Cytochrome P-450 CYP2C8 Inhibitors/administration & dosage ; Cytochrome P-450 CYP2C8 Inhibitors/chemical synthesis ; Cytochrome P-450 CYP2C8 Inhibitors/pharmacokinetics ; Cytochrome P-450 CYP2C8 Inhibitors/pharmacology ; Cytochrome P-450 CYP2C9 Inhibitors/administration & dosage ; Cytochrome P-450 CYP2C9 Inhibitors/chemical synthesis ; Cytochrome P-450 CYP2C9 Inhibitors/pharmacokinetics ; Cytochrome P-450 CYP2C9 Inhibitors/pharmacology ; Dogs ; Drug Stability ; Humans ; Inflammasomes/antagonists & inhibitors ; Interleukin-1beta/antagonists & inhibitors ; Mice, Inbred C57BL ; Microsomes, Liver/metabolism ; Molecular Structure ; NLR Family, Pyrin Domain-Containing 3 Protein/antagonists & inhibitors ; Pandemics ; Pneumonia, Viral ; Rats ; SARS-CoV-2 ; Structure-Activity Relationship ; Sulfonylurea Compounds/administration & dosage ; Sulfonylurea Compounds/chemical synthesis ; Sulfonylurea Compounds/pharmacokinetics ; Sulfonylurea Compounds/pharmacology
    Chemische Substanzen Cytochrome P-450 CYP2C8 Inhibitors ; Cytochrome P-450 CYP2C9 Inhibitors ; IL1B protein, human ; Inflammasomes ; Interleukin-1beta ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLRP3 protein, human ; Nlrp3 protein, mouse ; Sulfonylurea Compounds
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-09-24
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2020.127571
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 3203: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  3. Artikel: Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor

    Agarwal, Sameer / Pethani, Jignesh P / Shah, Hardik A / Vyas, Vismit / Sasane, Santosh / Bhavsar, Harsh / Bandyopadhyay, Debdutta / Giri, Poonam / Viswanathan, Kasinath / Jain, Mukul R / Sharma, Rajiv

    Bioorg Med Chem Lett

    Abstract: NLRP3 inflammasome mediated release of interleukin-1ß (IL-1ß) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent and orally bioavailable NLRP3 ... ...

    Abstract NLRP3 inflammasome mediated release of interleukin-1ß (IL-1ß) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent and orally bioavailable NLRP3 inhibitors. Compound 7 was found to be potent (IL-1ß IC50 = 35 nM; IL-18 IC50 = 33 nM) and selective NLRP3 inflammasome inhibitor with excellent pharmacokinetic profile having oral bioavailability of 99% in mice.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #791276
    Datenquelle COVID19

    Kategorien

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Zum Seitenanfang